Eli Lilly is requesting medical records from patients who took compounded versions of tirzepatide amid safety concerns and ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 589.81% and ...

Eli Lilly & Co. is asking people who took copies of its blockbuster weight loss drug to give the company access to their ...

Novo Nordisk A/S's shares have stalled recently, but this looks like a natural digestion of gains from prior years. Click for ...

One of the researchers described the circumstances that led to the discovery as “serendipity.” This year’s prestigious Lasker ...

Eli Lilly’s stock has climbed almost 60% this year and trades for more than $900. The pharma giant also has seen soaring ...

We recently compiled a list of the 10 Best Counter Cyclical and Defensive Stocks to Invest In. In this article, we are going ...

Shutterstock / Caroline Ruda In 2022, the FDA placed tirzepatide — the active ingredient in Eli Lilly’s Mounjaro and Zepbound ...

SOMAÍ Pharmaceuticals partners with Georgelle to offer Irish patients a broad range of cannabis-based medicines, expanding ...

The letter is the latest sign that the battle between the brand-name drug manufacturers and the companies that make and sell ...

In July 2024, Sanders co-wrote an opinion piece with President Joe Biden—published in USA Today—taking aim at both Novo and ...

Jim Cramer warned that if the housing market rally keeps going, it might lead to a sell-off if the Federal Reserve announces ...